ANTENGENE-B (06996) reported in its February 2026 monthly return that the authorized share capital remained at 2.00 billion ordinary shares, each with a par value of US$0.0001, representing a total authorized capital of US$200,000. The number of issued shares was unchanged at 679.24 million, with 202,500 shares in treasury, bringing the total to 679.45 million ordinary shares.

According to the report, 100,000 options under Antengene’s 2020 Equity Incentive Plan lapsed during the month, leaving 25.61 million share options outstanding under that plan. There were no new shares issued or transfers from treasury, and the total funds raised from option exercises stood at HKD 0. Meanwhile, 1.61 million restricted share units (RSUs) linked to new shares remained outstanding under the 2022 Restricted Share Unit Scheme. The report noted that, at month-end, up to 56.03 million shares could be issued through exercises of existing options and vesting of share awards.

The report further stated that the company continued to meet public float requirements, with no changes in treasury shares or any other movements in issued shares during the month.